LeadStory

Reuters

AstraZeneca invertirá 50.000 millones de dólares en EE.UU. ante la amenaza de los aranceles farmacéuticos

Reuters · 30 days ago
Reuters
Reuters
30 days ago

AstraZeneca planea gastar 50.000 millones de dólares para ampliar sus capacidades de fabricación e investigación en Estados Unidos de aquí a 2030, la última gran inversión de una farmacéutica que reacciona a la política arancelaria del presidente Donald Trump.

Breakdown
  • AstraZeneca will invest $50 billion in the US by 2030, including a new factory in Virginia.
  • The investment comes as the US considers tariffs on imported pharmaceuticals and urges more domestic production. 16s
  • AstraZeneca's CEO said global drug prices should equalize, with higher prices outside the US to support R&D. 32s
  • The US government has indicated tariffs may be imposed soon, with companies given up to 18 months to adjust. 47s
  • AstraZeneca's move follows similar investments by other major pharmaceutical firms and is expected to create tens of thousands of jobs. 1m 14s
Companies & StartupsBusiness